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“He that was dreaming…
Saw his dream through”
[Didi Manoussi,
popular Israeli songwriter]
Michel Mirowski (1924–1990)
Frequently important innovations in
medicine, and not only just in medicine, are
the consequence of circumstances. No one
will belittle Alexander Fleming’s contribu-
tion to the discovery of the miraculous ef-
fects of penicillin because his breakthrough
observation was realized when he stum-
bled upon mold falling from the roof of his
laboratory which inhibited the growths of
Staphylococcus aureus. On the other hand,
other inventors carefully plan and diligently pursue
an idea or a concept and Michel Mirowski, whose life
and achievements will be described here, belongs to
this category of geniuses. Michel had a dream and
he spent years of labor struggling to see it through.
Mieczyslaw Friedman was born in 1924 in
Warsaw, Poland to a Jewish family and his family
background and roots were admirably decribed by
John Kastor [1]. The change of their name to Mi-
rowski came from the family’s wish to blend easily
into Polish society. In 1939, with the break out of
WWII, Poland was in flames and 15 year old Mie-
czyslaw fled eastward and survived the next five
years with false papers, hiding in small villages and
forests while living in constant fear and danger.
After the war, returning to Warsaw, Mieczyslaw did
not find his father, brother or any other surviving
relatives. Alone, he went to Gdansk and enrolled
at the University to study medicine but after one
year, in 1947, he immigrated to pre-State Israel. As
there was no medical school there at the time, he
traveled then to Lyon, France where he completed
his medical training. Here he adopted the name Mi-
chel, and upon marrying Anna, they returned to
Israel in 1954. Michel then started his residency in
cardiology at the Tel Hashomer Hospital. He knew
however, that in order to become a first rate car-
diologist, he needs top overseas  training.
Upon receiving a fellowship, Michel ini-
tially worked at the Instituto de Cardiolo-
gica in Mexico City under Enrique Cabre-
ra and Sodi-Pallares then he transferred
to Baltimore, Maryland as a fellow of
Dr. Helen Taussig’s department. Only in
1963, after this extensive post-graduate
training, did he return to Israel with his
wife and three children.
In Israel Michel’s professional life was not wi-
thout obstacles. His desire to work as a senior
member at the large and prestigious Tel Hashomer
Hospital’s cardiology department, did not materia-
lize. Despite this set back he became a respected
member of Tel Hashomer’s Department of Medi-
cine and here started his life-long admiration of Prof.
Harry Heller, Head of the Department. Later Mi-
chel became the Head and sole doctor of the Car-
diology Unit at Assaf Harofe, a more peripheral
government hospital. During these years my friend-
ship with Michel started when he embarked upon
several research projects with the Cardiology De-
partment’s experimental laboratory of my hospital
in Jerusalem, Hadassah. This cooperation resulted
in lectures and publications on his then main rese-
arch interest, aberrant atrial rhythms [2].
A tragic event changed Mirowski’s life and ca-
reer in 1966, his mentor Prof. Heller died suddenly
after an episode of ventricular tachycardia termina-
ting in ventricular fibrillation while at home with his
family. Michel realized that the life of Heller and
many other patients could be saved if at the time of
the VT/VF they were in a coronary care unit and
defibrillated there, or, if a defibrillator would be
permanently available for them, probably implan-
ted into their body.
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This revolutionary concept of having a device
implanted permanently which can monitor and ana-
lyze cardiac rhythm and deliver promptly a low
energy shock to the heart whenever VT or VF oc-
curs, became Michel Mirowski’s life’s obsession.
When he felt that his hospital position and facilities
in Israel were too restricted to develop his idea, he
was ready to sacrifice his position and family secu-
rity to pursue his dream in America.
Sinai Hospital in Baltimore offered Michel the
position of Head of the ICCU and there he found
a close friend and collaborator in Dr. Morton Mo-
wer, with whom the first steps were taken in ma-
terializing his concept. In the animal laboratory they
succeeded in implanting a defibrillator device in
a dog and when it collapsed due to an induced
VT/VF, the device automatically launched a shock
to the heart, the animal immediately got up on its
feet and walked away.
In spite of  the dramatic videotape which most
convincingly documented that an implanted device
can recognize and terminate a VT/VF event and the
consequent publishing of his first report [3], the
scientific world not only rebuffed this concept but
even attacked Michel in an unusually harsh man-
ner. Lown and Axelrod [4] listed lengthily in a le-
ading cardiology journal’s Editorial their technical
and ethical considerations, calling implanted stand-
by defibrillators “an imperfect solution” and expres-
sed their view that “it was developed because it was
possible”.
Michel was not only personally “bruised” by
this editorial, as his daughter Ariella recalled [5],
but the whole advancement of the project was slo-
wed down by this vehement criticism. Only when
a new partner appeared on the scene, Dr. Stephen
Heilman who was ready to invest the necessary
funds for the continuation of the research, could the
project progress. In 1980 the first human implant
of a much more sophisticated device was success-
fully conducted, and thereafter published in a most
prestigious medical journal [6]. From now on the
success of the ICDs, the name by which the “Mi-
rowski device” became known all over the world,
never ceased. Between 1980–1985, more than 5,000
ICDs were implanted on both sides of the Atlantic.
Michel Mirowski’s achievements finally became ac-
cepted and highly regarded.
We in Jerusalem felt fortunate that Michel
accepted my invitation to attend our International
Holter Symposium in March 1986. All of us enthu-
siastically listened to his description of the “bum-
py road” in developing the ICD, as we watched with
fascination the video of its dramatic use on the dog
and admired his first hand account of the clinical
success and follow-up of 900 patients. My invita-
tion was only one of many for Michel Mirowski who
became an internationally sought after lecturer.
Now he really enjoyed the appreciation expressed
by all cardiologists and scientists in the world and
he saw how the device he envisioned is now saving
thousands of lives.
Fate was not gracious with Michel Mirowski.
At the peak of his success, when he could see his
dream come through, Michel was diagnosed with
multiple myeloma. At the time of my last personal
meeting with him and Anna in Italy, Michel hinted
to me about his health problem. Michel Mirowski’s
life was cut off in his prime as he died at the age of
66, mourned by Anna, their three daughters, and
his friends and patients all over the world.
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